198 related articles for article (PubMed ID: 4413555)
21. Synergistic cooperation between isoantiserum and immune lymphoid cells: in vitro studies with a syngeneic rat lymphoma.
Ortiz de Landazuri M; Kedar E; Fahey JL
J Immunol; 1974 Jun; 112(6):2102-10. PubMed ID: 4825787
[No Abstract] [Full Text] [Related]
22. In vitro methods for assessment of antibody-mediated tumor immunity.
Levy NL; Amos DB; Solovieff GV; dos Reis AP
Natl Cancer Inst Monogr; 1972 Dec; 35():5-11. PubMed ID: 4349154
[No Abstract] [Full Text] [Related]
23. Combined cytolytic effect of x irradiation and cell-mediated immune reactions on tumor cells in vitro.
Song CW; Levitt SH
Radiology; 1974 Apr; 111(1):211-2. PubMed ID: 4205812
[No Abstract] [Full Text] [Related]
24. Cytotoxicity of vivo sensitized lymphocytes on allogeneic third-party fibroblasts differing for various regions of the H-2 complex.
Jorgensen PN; Florentz K; Güttler F
Transplant Proc; 1974 Mar; 6(1):95-9. PubMed ID: 4817057
[No Abstract] [Full Text] [Related]
25. Serum factors in mammary neoplasia: enhancement and antagonism of spleen cell activity in vitro detected by different methods of serum factor assay.
Blair PB; Lane MA
J Immunol; 1974 Feb; 112(2):439-53. PubMed ID: 4813898
[No Abstract] [Full Text] [Related]
26. Secondary cytotoxic tumor immune response induced in vitro.
Röllinghoff M
J Immunol; 1974 May; 112(5):1718-25. PubMed ID: 4544796
[No Abstract] [Full Text] [Related]
27. A quantitative radioisotopic assay for hemolytic antibody by employing technetium-99m-labeled erythrocytes.
Barth RF; Singla O
J Immunol; 1974 Feb; 112(2):756-62. PubMed ID: 4813905
[No Abstract] [Full Text] [Related]
28. Development and inhibition of cytotoxic antibody against spontaneous murine breast cancer.
Stolfi RL; Fugmann RA; Stolfi LM; Martin DS
J Immunol; 1975 Jun; 114(6):1824-30. PubMed ID: 1127230
[TBL] [Abstract][Full Text] [Related]
29. Contrasting effects of alloandtiserum and xenoantiserum on cell-mediated lysis of tumor cells.
Sonis ST; Stelos P; Kopelman JD; Wilson RE
Cell Immunol; 1975 Apr; 16(2):251-60. PubMed ID: 1078791
[No Abstract] [Full Text] [Related]
30. In vitro demonstration of complement-dependent cytotoxic antibodies to Moloney sarcoma cells.
Tamerius JD; Hellström I
J Immunol; 1974 Jun; 112(6):1987-96. PubMed ID: 4825783
[No Abstract] [Full Text] [Related]
31. Complement-mediated alteration of antibody specificity in vivo.
Drake WP; Mardiney MR
J Immunol; 1975 Mar; 114(3):1052-7. PubMed ID: 46259
[TBL] [Abstract][Full Text] [Related]
32. Studies on the induction and expression of T cell-mediated immunity. I. Blocking of cell-mediated cytolysis by membrane antigens.
Bonavida B
J Immunol; 1974 Mar; 112(3):926-34. PubMed ID: 4544178
[No Abstract] [Full Text] [Related]
33. Effect of anti-mouse IgG on some complement-requiring alloantibodies of the mouse.
Harris TN; Harris S
J Immunol; 1972 Nov; 109(5):1096-108. PubMed ID: 4627933
[No Abstract] [Full Text] [Related]
34. Cytotoxic immune cells with specificity for defined soluble antigens. V. Interaction of antibody with the cytotoxic effector cells in immune or non-immune mouse spleen cells.
Schirrmacher V; Rubin B; Pross H
J Immunol; 1974 Jun; 112(6):2219-26. PubMed ID: 4856907
[No Abstract] [Full Text] [Related]
35. In vivo studies of the role of cytotoxic T cells in tumor allograft immunity.
Freedman LR; Cerottini JC; Brunner KT
J Immunol; 1972 Dec; 109(6):1371-8. PubMed ID: 4538966
[No Abstract] [Full Text] [Related]
36. Antibody-dependent cell-mediated cytotoxicity. II. Early interactions between effector and target cells.
Scornik JC
J Immunol; 1974 Nov; 113(5):1519-26. PubMed ID: 4418199
[No Abstract] [Full Text] [Related]
37. The role of macrophages in the cytotoxic killing of tumour cells in vitro. I. Primary immunization of lymphocytes in vitro for target cell killing and the mechanism of lymphocyte-macrophage cooperation.
Zembala M; Ptak W; Hanczakowska M
Immunology; 1973 Oct; 25(4):631-44. PubMed ID: 4356674
[TBL] [Abstract][Full Text] [Related]
38. Specific cytolytic activity of lymphocytes: effect of antibodies against complement components C2, C3, and C5.
Henney CS; Mayer MM
Cell Immunol; 1971 Dec; 2(6):702-5. PubMed ID: 5005914
[No Abstract] [Full Text] [Related]
39. Antibody response to ATPC+ascites tumour in mice rendered resistant by intravenous inoculation of liver cells.
Pitzurra M; Marconi P
Boll Ist Sieroter Milan; 1972; 51(5):393-404. PubMed ID: 4656954
[No Abstract] [Full Text] [Related]
40. Interaction of isoantibody and cytotoxic lymphocytes with allogeneic tumor cells.
Faanes RB; Choi YS
J Immunol; 1974 Jul; 113(1):279-88. PubMed ID: 4208919
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
